Agilent Technologies, Inc. $A Shares Bought by Pacific Heights Asset Management LLC

Pacific Heights Asset Management LLC raised its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 25.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 150,000 shares of the medical research company’s stock after acquiring an additional 30,000 shares during the period. Pacific Heights Asset Management LLC owned 0.05% of Agilent Technologies worth $20,410,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of A. Board of the Pension Protection Fund acquired a new position in Agilent Technologies in the 4th quarter valued at $27,000. Navalign LLC acquired a new position in Agilent Technologies in the 4th quarter valued at $27,000. Physician Wealth Advisors Inc. raised its holdings in Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after acquiring an additional 196 shares during the last quarter. Torren Management LLC acquired a new position in Agilent Technologies in the 4th quarter valued at $32,000. Finally, State of Wyoming acquired a new position in Agilent Technologies in the 2nd quarter valued at $35,000.

Agilent Technologies Stock Down 0.0%

Shares of NYSE A opened at $111.69 on Monday. Agilent Technologies, Inc. has a 52-week low of $107.07 and a 52-week high of $160.27. The firm has a fifty day moving average of $115.06 and a 200-day moving average of $130.57. The stock has a market capitalization of $31.56 billion, a PE ratio of 24.66, a P/E/G ratio of 2.35 and a beta of 1.22. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:AGet Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Wall Street Analysts Forecast Growth

A has been the subject of several analyst reports. HSBC initiated coverage on Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target for the company. Wall Street Zen downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. UBS Group cut their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. TD Cowen lowered their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, Barclays lowered their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Buy” and an average target price of $163.71.

Read Our Latest Stock Report on A

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Featured Stories

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.